Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Non-cash Items (2017 - 2022)

Arcus Biosciences (RCUS) has 6 years of Non-cash Items data on record, last reported at $6.7 million in Q4 2022.

  • For Q4 2022, Non-cash Items fell 97.36% year-over-year to $6.7 million; the TTM value through Dec 2022 reached $6.7 million, down 97.36%, while the annual FY2022 figure was $6.7 million, 97.36% down from the prior year.
  • Non-cash Items reached $6.7 million in Q4 2022 per RCUS's latest filing, down from $253.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $253.6 million in Q4 2021 and bottomed at $1.1 million in Q4 2019.
  • Average Non-cash Items over 5 years is $55.1 million, with a median of $6.7 million recorded in 2022.
  • Peak YoY movement for Non-cash Items: skyrocketed 8980.4% in 2021, then crashed 97.36% in 2022.
  • A 5-year view of Non-cash Items shows it stood at $11.0 million in 2018, then plummeted by 89.59% to $1.1 million in 2019, then surged by 143.87% to $2.8 million in 2020, then surged by 8980.4% to $253.6 million in 2021, then plummeted by 97.36% to $6.7 million in 2022.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $6.7 million in Q4 2022, $253.6 million in Q4 2021, and $2.8 million in Q4 2020.